CARE CF 1 Lynovex clinical trial data selected for presentation at NACFC 2018.

NovaBiotics today announces that the results from the recently completed CARE CF 1 clinical study for oral Lynovex in cystic (CF) exacerbations have been accepted for presentation at the North American Cystic Fibrosis Conference (NACFC), Denver, CO, October 18-21, 2018. NACFC is organised by the Cystic Fibrosis Foundation and is a key annual event that brings together clinicians, scientists, caregivers, industry and all CF community stakeholders.